{"listing":{"listing_type":"company","name":"Granza Bio","slug":"granza-bio","tagline":"Building programmable therapeutics for the immune system","description":"Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.\n\nGranza Bio is a Y Combinator company (Winter 2024). YC-listed status: Active.","url":"https://www.granzabio.com/","is_stealth":false,"normalized_domain":"granzabio.com","normalized_url_key":"granzabio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/e4fe5f43800f16c0ca16303f58b955037e3f2bc1.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/granza-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.granzabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.granzabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:45:07.063Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2024","Synthetic Biology","Biotech","Healthcare","Therapeutics","Oncology"],"one_liner_for_search":"Granza Bio — Building programmable therapeutics for the immune system (Y Combinator Winter 2024)","canonical_facts":["Y Combinator batch: Winter 2024","YC company status: Active","Team size (per YC directory): 8","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Zyme Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:45:07.063Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}]}}